Skip to main content
. 2022 May 5;11(9):1557. doi: 10.3390/cells11091557

Figure 2.

Figure 2

Meta-analysis for the studies of ANXA11 rs1049550 and phenotypes of Sarcoidosis. (A) Forest plot of the results for resolving and chronic sarcoidosis patients. (B) Forest plot of the results for Löfgren’s syndrome and non-Löfgren’s syndrome patients. Dotted line represents the odds ratio from the combined analysis. OR: Odds ratio, 95% CI: 95% confidence interval.